Mupirocin EP Impurity C Sodium salt is chemically (4E)-9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl] methyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]non-4-enoic acid Sodium salt (as per EP); (E)-9-{(E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxy butan-2-yl]oxiran-2-yl}methyl)tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyloxy}non-4-enoic acid Sodium salt (as per USP). It is also known as Pseudomonic acid D (USP). Mupirocin EP Impurity C Sodium salt is supplied with detailed characterization data compliant with regulatory guideline. Mupirocin EP Impurity C Sodium salt can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mupirocin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.